The threat of the coronavirus diminished for many Americans thanks to the COVID vaccines. What have we learned from the experience? What does the future look like for vaccine science and accessibility?
On this special edition of the RCP Takeaway, RealClear Health and RealClear Policy editor Jerry Rogers hosts a conversation on the value, science, and policies surrounding vaccines.
Panelists include Eric Hargan, CEO of The Hargan Group, Kirsten Axelsen of the American Enterprise Institute (AEI), Randall Lutter of the Manhattan Institute, and Dr. Henry I. Miller of The American Council on Science and Health. This program ismade possible with financial support from Pfizer.
